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ABSTRACT
Objective: This work was performed to evaluate the effect of priming with exogenous sources of calcium ion and nitric oxide on the antidiabetic 
activity and the alkaloid contents of fenugreek sprouts along with isolation and identification of trigonelline, a bioactive alkaloid responsible for 
hypoglycemic property of fenugreek.
Methods: The fenugreek seeds were pre-treated with calcium chloride (CC), lanthanum chloride (LC) a calcium channel blocker; 
ethylene glycol-bis (2-aminoethylether) -N, N, N´, N tetra acetic acid (EG) a calcium chelator; sodium nitroprusside (SNP) and 
2-(4-carboxyphenyl) -4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (CP) a nitric oxide scavenger and germinated for 72 hrs. The sprout extracts 
were evaluated for their in vitro antidiabetic potential by α-amylase and α-glucosidase inhibition along with their trigonelline content. Trigonelline 
was isolated from fenugreek sprouts and identified by Infrared analysis and nuclear magnetic resonance (NMR) spectroscopy.
Results: The results revealed that sprouts pre-treated with CC and SNP exhibited enhanced antidiabetic potential as well as alkaloid content over 
control; on the other hand, their action was reversed by their antagonists, EG, LC, and CP. The sprouts pre-treated with 2mM CC showed the best 
elicitation of alkaloid content and antidiabetic activity followed by SNP-20 mM.
Conclusions: The study suggests probable involvement of the signaling molecules, calcium ion, and nitric oxide in pathways associated with 
biosynthesis of bioactive compounds responsible for hypoglycemic activity of fenugreek sprouts one of which being trigonelline.
Keywords: Antidiabetic, Calcium, Fenugreek sprouts, Nitric oxide, Priming, Trigonelline, Nuclear magnetic resonance.
INTRODUCTION
Plants are the basic source of knowledge of modern medicine. Almost 
all the parts of a plant, namely leaves, flowers, fruits, bark, roots, stem, 
and seeds are known to have various medicinal properties [1]. The 
trend of using natural products has increased, and the active plant 
extracts are frequently screened for new drug discoveries and for the 
presence of potential bioactive components [2,3].
India with the highest number of people suffering from diabetic 
disorders has been considered as the diabetic capital of the world 
by the “International Journal of Diabetes in Developing Countries.” 
There is an alarming rise in diabetes patients in India; approximately 
3.4 million deaths occur due to complication related to high blood 
sugar [4].
Diabetes mellitus is a serious metabolic disorder that leads to 
hyperglycemic condition due to decreased insulin production 
or inefficient insulin utilization. It is usually characterized by 
hyperglycemia, lipoprotein abnormalities, high basal metabolic rate, 
impairment in the activity of important enzymes, and oxidative stress 
which damages the pancreatic beta cells. It is the most common 
endocrine disorder which disrupts glucose homeostasis causing 
severe diabetic associated complications in major organs such as eye, 
blood vessels, and brain [5,6]. Multiple risk factors responsible for 
the disease to occur include persistent stress and depression, obesity, 
environmental pollutants, and sedentary lifestyle [7].
Some of the synthetic antidiabetic components such as metformin, 
acarbose, biguanides, and voglibose are found to be used clinically in 
combination with another diet to control diabetes, but moreover, they 
exhibit adverse side effects after long term use [8-10]. To prevent or 
overcome the side effects of these synthetic drugs and also to create 
other safer alternative drug choices, it has become essential to seek 
other inhibitors for further drug development. Thus, in recent years, 
several efforts have been made for increasing the availability of 
glucosidase inhibitors from natural sources [11,12].
Likewise, fenugreek besides having several pharmacological 
properties it is also reported to possess potent antidiabetic 
property both in vitro and in vivo system. Fenugreek is known 
to be a rich source of various bioactive components having a 
different therapeutical property such as sapogenins, fenugreekine, 
nicotinic acid, phytic acid, and trigonelline [13,14]. Trigonelline is a 
pyridine alkaloid known to be mostly found in Fabaceae members 
and is reported to be metabolically active as a hypocholesterolemic 
agent along with potential hypoglycemic effect [15-18]. Fenugreek 
has been successfully implemented as antidiabetic remedy for both 
types I and II diabetes [19]. Moreover, fenugreek has been reported 
to be enriched with wide spectrum of pharmacological and folkloric 
significance [20].
This study deals with the isolation and identification of trigonelline 
by 1-D and 2-D nuclear magnetic resonance (NMR) from fenugreek 
sprouts. Further, the elicitors of calcium and nitric oxide were applied 
for the enhancement in the alkaloid content of fenugreek sprouts 
along with the in vitro antidiabetic property. This study may provide 
an insight in the role of these signaling molecules in modulating the 
biosynthesis of alkaloids, a potential hypoglycemic agent; in addition, 
the utility of 2-D NMR spectroscopy in identification of bioactive 
compounds.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i4.16910
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METHODS
Priming and sprouting
The fenugreek seeds were surface sterilized with 0.1% sodium 
hypochlorite solution. After sterilization, the seeds were washed thrice 
with distilled water and subjected to priming with the solutions of 
calcium chloride (CC), an exogenous source of calcium ion; a calcium 
chelator: Ethylene glycol-bis (2-aminoethylether)-N,N,N´,N, tetra 
acetic acid (EG); a calcium channel blocker: Lanthanum chloride (LC); 
sodium nitroprusside (SNP) as an exogenous source of nitric oxide and 
2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide 
(CP), a nitric oxide scavenger. The priming agents applied in various 
combinations are given in Table 1. For control set, seeds were primed 
with normal water and kept in a rotary shaker along with the treated 
seeds. After priming for 24 hrs, the seeds were again washed thrice 
with sterile water and kept in the seed germinator for germination for 
72 hrs.
Determination of antidiabetic property by in vitro method
Preparation of extract
The fenugreek sprouts of three different stages: 24 hrs, 48 hrs, and 
72 hrs were crushed in mortar-pestle and individually processed 
through Soxhlet extraction apparatus with methanol for 8 hrs duration. 
The refluxed samples were separated from the residues by filtering 
through Whatman No. 1 filter paper, and the extract was concentrated 
to a uniform concentration of 1 g/ml using a vacuum rotary evaporator 
at 50°C. The obtained methanolic extracts were further used for 
experimental analysis for determination of antidiabetic activity and 
total alkaloid estimation.
Inhibition of α-amylase (AA) enzyme activity
The AA inhibition potential of the extract was estimated by standard 
spectrophotometric method [21]. 0.5 ml of aqueous extract was reacted 
with 0.5 ml of AA solution and incubated at 37°C for 5 minutes. After 
incubation, 0.5 ml starch solution (1%) was added and was further 
incubated for 10 minutes. To the above reaction mixture, 1 ml of 
DNSA reagent was added to terminate the reaction and was heated for 
10 minutes in a hot water bath till the color of reaction mixture color 
changed to orange-red. After change in color, the reaction mixture 
was cooled and diluted up to 5 ml with distilled water. The OD value 
was measured at 540 nm. The AA inhibitory activity was estimated by 
measuring the concentration of inhibitor required to inhibit 50% of the 
enzyme activity.
% inhibition = (A540 control-A540 sample)/(A540 control)×100
Where A540 control = Absorbance of control at 540 nm and 
A540 sample = Absorbance of sample at 540 nm.
Inhibition of α-glucosidase (AG) enzyme activity
The AG inhibitory property of the sample extract was assayed 
according to Dong et al. [22] with slight modifications. The 
reaction was initiated with 0.05 ml each of the samples at different 
concentrations in 0.2 mM phosphate buffer (pH 6.8), followed by 
incubation at 37°C for 15 minutes, after which 0.1 ml of enzyme 
solution was immediately added to the mixture before mixing and 
incubation at 37°C. Then, 3 mM p-nitrophenyl glucopyranoside 
(pNPG) (0.25 ml) was added, after which the reaction was terminated 
by the addition of 4 ml of 0.1 M Na2CO3. AG inhibitory activity was 
determined by measuring the release of pNPG at 405 nm. The control 
contained all reagents without the tested sample. The reactions were 
conducted in triplicate. The AG inhibitory activity was calculated as 
follows:






Where Ac, As, and Ab represent the absorbance levels of the control, 
sample, and blank, respectively. The concentration of AG inhibitor 
required to inhibit 50% of AG activity under the assay conditions is 
defined as the concentration inhibition 50% (IC50) value.
Total alkaloid estimation
The extract was gently heated, and methanol was evaporated on a 
rotary evaporator under vacuum at a temperature of 45°C to dryness. 
The residue was dissolved in 2 N HCl and then filtered. 1 ml of this 
solution was transferred to a separation funnel and washed with 10 ml 
chloroform (3 times). The pH of this solution was adjusted to neutral 
with 0.1 N NaOH. Then, 5 ml of Bromocresol Green solution and 5 ml 
of phosphate buffer were added to this solution. The mixture was 
shaken and the complex formed was extracted with 5 ml chloroform 
by vigorous shaking. The extracts were collected in a 10 ml volumetric 
flask and diluted to the same volume with chloroform. The absorbance 
of the complex in chloroform was measured at 470 nm against 
blank [23]. Similarly, trigonelline content was also estimated from the 
purified extract.
Isolation of trigonelline
The extraction procedure was followed as suggested by Ahmed 
et al. [24] with some modifications. The fenugreek sprouts of about 
100 g were homogenized in 10 M HCl solution and gently boiled 
for 2 hrs in an Erlenmeyer flask. Next, the mixture was filtered, and 
zinc dust was added to the mixture and kept on a magnetic stirrer 
for overnight. In next morning, the mixture was filtered again and 
extracted with equal volume of dichloromethane (CH2Cl2). The CH2Cl2 
layer containing the alkaloid was separated and later evaporated. 
The obtained extract after CH2Cl2 evaporation was reconstituted in 
methanol for further analysis.
Thin layer chromatography (TLC)
The extract dissolved in methanol was applied manually on 
activated TLC plates, along with standard trigonelline. After loading 
the samples, the TLC plates were developed in presaturated 
chromatography solvent chamber containing solvent system composed 
of ethylacetate:methanol:H2O (100:13.5:10). After running the solvent 
through the TLC plates, the plates were sprayed with Dragendorff’s 
reagent to develop spot corresponding to standard trigonelline 
simultaneously.
After confirming the presence of trigonelline, in next TLC experiment 
after running the solvent through the TLC plate, the portion of plate 
containing pure trigonelline was cut and sprayed with Dragendorff’s 
reagent and then the area of TLC plate containing unknown extract 
corresponding to band developed on the plate with standard 
trigonelline was scrapped and collected, dried and later dissolved in 
methanol for further quantitative, and spectral analysis.
Infrared (IR) spectral analysis
IR spectra of the crude, purified sample and standard trigonelline were 
recorded on FTIR spectrophotometer (model: 8300 Shimadzu) by Nujol 
mulling for liquid sample and KBr pellets for solid sample.
Table 1: Different priming agents applied
Calcium elicitors Nitric oxide elicitors
T0 H2O T0 H2O
Tc1 CC-1 mM Tn1 SNP-10 mM
Tc2 CC-2 mM Tn2 SNP-20 mM
Tc3 CC-5 mM Tn3 SNP-40 mM
Tc4 CC-1 mM+EG500 µM Tn4 SNP-80 mM
Tc5 CC-2mM+EG500 µM Tn5 SNP-120 mM
Tc6 CC-5 mM+EG500 µM Tn6 SNP10 mM+CP125 µM
Tc7 EG-2 mM Tn7 SNP20 mM+CP125 µM
Tc8 CC-1 mM+LC500 µM Tn8 SNP40 mM+CP125 µM
Tc9 CC-2 mM+LC500 µM Tn9 SNP80 mM+CP125 µM
Tc10 CC-5 mM+LC500 µM Tn10 SNP120 mM+CP125 µM
Tc11 LC-2 mM Tn11 CP125 µM
CC: Calcium chloride, SNP: Sodium nitroprusside, LC: Lanthanum chloride
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NMR analysis
The confirmation of the structure of the extracted compound was done 
by NMR- spectra in 300 MHZ Bruker-Avance spectrometer using 5 mm 
BBO probe and Methanol-d4 was used as a solvent.
Statistical analysis
Each experiment was performed in triplicate. The software package, 
MS Excel 2007 (Microsoft, Redmond, WA, USA) was used for comparing 
the antidiabetic activity and alkaloid content of the fenugreek sprouts. 
The different group means were compared by Tukey’s multiple range 
test through DSAASTAT software (version 1.002; DSAASTAT, Perugia, 
Italy); p<0.05 was considered significant in all cases. Smith’s Statistical 
Package version 2.5 (prepared by Gary Smith, CA, USA) was used for 
determining the IC50 values of antidiabetic activity and their standard 
error of estimates.
RESULTS AND DISCUSSION
The key enzymes in the digestive system, AA and AG are actively 
involved in the release of glucose in the blood via breakdown of 
starch. Hence, the inhibition of these enzymes would minimize the 
breakdown of starch, which may lead to a reduction in the post-prandial 
hyperglycemic level [25]. Therefore, determination of the capability 
of an extract to inhibit the activity of these enzymes AA and AG is 
essential for investigating the antidiabetic potentiality of the extract. 
Since fenugreek has been well known for its antidiabetic activity, this 
study aimed at enhancing the antidiabetic activity of fenugreek sprouts 
through elicited sprouting. The inhibition capacity of the sprouts was 
expressed in terms of IC50 values. The results revealed that the fenugreek 
sprouts exhibited potential antidiabetic property, and interestingly, it 
was also observed that the exogenous supply of Ca2+ and nitric oxide 
resulted in the enhancement of this activity in fenugreek sprouts. Both 
AA and AG inhibition capacity of fenugreek sprouts was enhanced by CC 
(Table 2) and SNP (Table 3).
In many plant species alkaloids get accumulated in seeds in relatively high 
concentration as a chemical defense. During germination, alkaloids get 
metabolized, and their nitrogen is reused for seedling’s metabolism [26]. 
The antidiabetic property of most legumes including fenugreek is usually 
attributed to their trigonelline content, an alkaloid with scientifically 
well characterized hypoglycemic effect [14,27]. Trigonelline is reported 
to act by regulating cell regeneration, insulin secretion, enzymes 
associated with glucose metabolism. It is further known to mitigate 
oxidative stress during the diabetic complications [28,29]. Considering 
such potential role of alkaloids in controlling the diabetic disorders, the 
alkaloid content of the fenugreek seedlings subjected to various priming 
agents was determined. Interestingly, it was found that the sprouts 
pre-treated with CC and SNP exhibited significantly higher alkaloid 
content with respect to control sprouts. Similar trend in the effect of 
different priming agent was observed in the trigonelline content of the 
fenugreek sprouts (Fig. 1). The potential hypoglycemic property of 
trigonelline was further supported by our results which clearly depicted 
the significant influence of trigonelline content on the AG (Fig. 2) and 
AA (Fig. 3) inhibitory capacity of fenugreek sprouts pre-treated with 
different priming agents. On the other hand, the antagonists, EG, LC, 
and CP showed inhibitory effect on the alkaloid accumulation in the 
sprouts. In agreement to the earlier cited statement, it was noted that 
the sprouts with the higher trigonelline content exhibited stronger AG 
and AA inhibition activity thus suggesting the probable role of alkaloids 
especially trigonelline as hypoglycemic compounds in the management 
of diabetic disorders. Furthermore, various authors have proved that the 
enhancement in the hypoglycemic activity of fenugreek is considerably 
associated with an increase in the level of bioactive components such as 
trigonelline and 4-hyroxy leucine [24,30,31].
Table 2: In vitro AA and α-glucosidase inhibition activity of fenugreek sprouts under the influence of different calcium elicitors
Treatment 24 hrs 48 hrs 72 hrs
AG (mg/ml) AA (mg/ml) AG (mg/ml) AA (mg/ml) AG (mg/ml) AA (mg/ml)
T0 1010±47.76b 1186.75±38.72c 715.20±31.24c 840.36±42.36d 1122.81±29.98d 1319.30±24.21c
Tc1 336.52±28.05a 619.20±15.02b 330.0±22.37a 607.20±12.08b 717.50±21.94b 1320.20±19.12c
Tc2 339.42±22.32a 522.71±10.33a 301.12±13.77a 463.71±20.48a 599.80±17.04a 923.69±14.34a
Tc3 348.94±16.69a 502.48±12.05a 464.68±23.13b 669.15±23.95c 795.38±18.69c 1145.35±12.72b
Tc4 1055.23±22.42b 1202.97±32.15c 773.20±16.08d 1345.36±27.99i 1176.25±27.24d 1576.17±18.79e
Tc5 1593.33±12.54d 1386.20±36.44e 1289.22±18.33g 1121.43±11.86f 1869.88±39.97h 1626.79±16.76ef
Tc6 1634.5±15.69d 1291.97±9.56d 1610.71±25.36h 1272.46±13.40h 1906.36±23.15h 1506.02±23.17d
Tc7 2276.66±29.58e 1707.50±24.45f 1732.11±17.87i 1299.08±13.25hi 2284.50±13.73i 1713.37±13.90g
Tc8 1047.41±10.56b 1199.29±13.22c 832.85±12.42e 953.63±10.55e 1326.92±15.67e 1519.32±17.09d
Tc9 1141.54±12.36c 1284.23±12.42d 1075.21±19.11f 1209.62±19.23g 1598.89±17.14f 1798.75±20.33h
Tc10 1148.09±9.44c 1287.02±8.56d 1258.18±12.45g 1410.42±17.19j 1738.04±12.05g 1885.77±18.90i
Tc11 2545±34.22f 1679.70±22.72f 1294.58±14.62g 1513.34±12.14k 1700.80±11.36g 1632.76±18.24df
Results are represented as mean±standard error of mean, n=3. Values with different letters (a-k) are significantly (p<0.05) different from each other by Tukey’s multiple 
range test, AA: α-amylase
Table 3: In vitro AA and α-glucosidase inhibition activity of fenugreek sprouts under the influence of different nitric oxide elicitors
Treatment 24 hrs 48 hrs 72 hrs
AG (mg/ml) AA (mg/ml) AG (mg/ml) AA (mg/ml) AG (mg/ml) AA (mg/ml)
T0 1010±47.76e 1186.75±38.72de 715.20±31.24c 840.36±42.36d 1122.81±29.98d 1319.30±24.21c
Tn1 533.33±22.16b 981.33±11.05c 420.01±9.22ba 772.8±8.72c 765.14±21.94b 1407.86±18.44d
Tn2 377.86±12.78a 581.90±12.62a 350.91±8.56a 540.41±7.16a 630.38±17.04a 970.78±8.54a
Tn3 635.81±8.15c 915.57±9.29b 451±11.05b 649.44±7.95b 839.75±18.69c 1209.25±12.05b
Tn4 822.96±12.33d 1431.95±12.67f 836.32±12.06d 1455.21±18.52g 1215.47±27.24e 2114.92±22.48i
Tn5 1313.16±11.22g 1497.0±26.38g 1464.12±19.14i 1669.09±18.32h 1962.27±39.97i 2236.99±19.86j
Tn6 1341.30±12.56gh 1166.93±9.08d 1354.88±14.17h 1178.75±10.22f 2375.56±23.15j 2066.73±21.62hi
Tn7 1160.0±9.42df 1032.40±14.12bc 1197.09±12.32f 945.71±8.25e 1992.78±13.73i 1574.29±18.24e
Tn8 1071.33±11.24f 1229.90±8.54e 1146.82±13.16e 860.11±8.66d 1406.67±15.67f 1448.86±16.92d
Tn9 1376.40±13.05h 1575.97±14.16h 1294.28±12.11g 1481.95±18.45g 1625.24±17.14g 1860.90±24.68f
Tn10 1704.09±19.19j 1917.0±17.32j 1820.76±22.04k 2048.36±24.35j 1819.86±12.05h 2047.33±18.78h
Tn11 1559.38±14.22i 1748.06±21.41i 1608.13±14.28j 1802.71±22.08i 1768.12±11.36h 1982.06±21.86g
Results are represented as mean±standard error of mean, n=3. Values with different letters (a-k) are significantly (p<0.05) different from each other by Tukey’s multiple 
range test, AA: α-amylase
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Further, two-way ANOVA analysis with replication was performed 
to determine the impact of different priming agents and various 
germination stages on antidiabetic and trigonelline content of 
fenugreek sprouts. As a result, a significant impact of both variance, 
i.e., priming agents and germination stages was found on the AA and 
AG inhibitory activity along with the trigonelline content (Table 4). 
Interactions between both were also significant at p<0.05 level.
The crude and purified extracts of fenugreek sprout were subjected to 
IR spectral analysis. The finger print region of both crude and purified 
extracts matched exactly with the that of standard trigonelline (Fig. 5), 
this indicates all the samples are of same nature, and further confirms 
the predominance of trigonelline in both extracts (crude and purified). 
In the frequency range 3000 to 3500 cm−1 broad strong absorption 
indicates the presence of -OH groups, both intra and intermolecular 
H-bonded. At 1715 cm−1 the absorption corresponds the presence of 
carboxylic acid group. The presence of some sharp medium absorption 
peaks at around 2725 cm−1 indicates the presence of C=C-H aromatic 
bonds supported by the presence of aromatic ring unsaturation 
vibrational bands around 1600 cm−1, the weak absorption for the 
ring bending of benzene derivatives in the range of 900 cm−1 was also 
observed. The aliphatic C-H stretching modes at around 2900 cm−1 
are masked with that of the Nujol. After confirming, the presence of 
trigonelline in purified extract by IR analysis the extract was further 
analyzed by NMR spectroscopy.
The implementation of NMR spectroscopy for metabolite fingerprinting 
has been considered highly reliable by the researchers. One-dimensional 
NMR (1D-NMR) spectra have been used successfully for analyzing 
compounds in a crude extract, further two-dimensional NMR (2D-NMR) 
spectra have been reported to be more efficient in the identification of 
bioactive compounds in plant extracts [32,33]. Likewise, the purified 
extract was subjected to 2D-NMR for the identification of compound. 
The proton (1H) NMR spectra derived from the purified extract of 
fenugreek were characterized by N+-CH3 (3H) peak at 4.5 ppm (δ); 
aromatic protons are observed at 8.1 ppm (δ) (1H), at 9 ppm (δ) 
(2H) and at 9.3 ppm (δ) (1H). In proton correlated spectroscopy and 
total correlation spectroscopy spectra, the correlation of the protons 
is confirmed and in the heteronuclear correlation spectra correlation 
of the spectra with that of carbon shifts are ascertained. This spectral 
analysis unequivocally suggests that the purified extract contains 
1-methylpyridinium-3-carboxylate (trigonelline). The 1H NMR spectra 
of purified fenugreek extract are depicted in (Figs. 5 and 6). The other 
spectra are annexed in the supplementary files.
Overall, it was observed that among all treatments, CC and SNP priming 
exhibited enhancement in the alkaloid and antidiabetic potential of 
fenugreek, among which CC was found to exhibit the best result. Such 
enhancement in the antidiabetic activity and the level of trigonelline in 
fenugreek has reported by various authors through biotic and abiotic 
elicitors [24,34]. The therapeutic property of trigonelline is highly 
attributed to its hypoglycemic effect, thus the enhancement in the 
biosynthesis of alkaloids further boosts the antidiabetic potential of the 
plant. The observation of best antidiabetic activity of sprouts during 
48 hrs stage indicates that the components including trigonelline 
responsible for the therapeutic potential were elicited appropriately at 
this stage. The impact of nitric oxide scavenger (CP), calcium chelator 
(EG) and calcium channel blocker was also assessed on the antidiabetic 
as well as alkaloid content of the fenugreek sprouts. The effect of these 
elicitors was found to be deteriorative on both aspects of the sprouts, 
i.e., therapeutic (antidiabetic) as well phytochemical (alkaloid) content.
CONCLUSION
It can be suggested that the increase in the alkaloid content was found 
to be responsible for the enhancement in antidiabetic property of 
fenugreek sprouts. The negative effects of the antagonists of calcium 
and nitric oxide indicate that the flux of these signaling molecules within 
the cellular system is essential during germination phases to regulate 
Fig. 1: Effect of different priming agents on the total alkaloid and 
trigonelline contents of fenugreek sprouts
Fig. 2: Effect of different priming agents on the trigonelline 
contents and α-glucosidase inhibition activity of fenugreek 
sprouts
Fig. 3: Effect of different priming agents on the trigonelline 
contents and α-amylase inhibition activity of fenugreek sprouts
Fig. 4: Infrared spectra of crude extract and thin layer 
chromatography purified extract compared with standard 
trigonelline
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the mechanisms responsible for the biosynthesis of antidiabetic 
compounds. The presence of trigonelline as a major alkaloid component 
was further confirmed by IR and NMR analysis. Thus, this knowledge 
can be used to design the priming based sprouting techniques which 
might have potential application in improving the nutraceutical quality 
of legume sprouts.
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